Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Source:http://linkedlifedata.com/resource/pubmed/id/11457741

Circulation 2001 Jul 17 104 3 257-62

Download in:

View as

General Info

PMID
11457741